Dr. Michael Roizen, MD

Bio

Michael F. Roizen, MD, a Sharecare Editorial Advisory member, is a Phi Beta Kappa graduate of Williams College, Alpha Omega Alpha graduate of the University of California, San Francisco, School of Medicine, and is board certified in both Anesthesiology and Internal Medicine. In 2007 Dr. Roizen was named the Chief Wellness Officer (the first such position in a major healthcare institution in the United States) for Cleveland Clinic, and Chair of its Wellness Institute. Dr. Roizen co-founded RealAge and chairs its Scientific Advisory Board. He is 64 calendar years of age, but his RealAge is 44.3. He and Dr Oz have authored 8 NY Times bestsellers between them, and three separately, including 4 #1 NY Times Bestsellers, including RealAge, Are You As Young As You Can Be, YOU: The Owner’s Manual, YOU: On A Diet, the Owner’s Manual for Waist Management, and YOU Staying Young, the Owner’s Manual for Extending Your Warranty.

Specialties:

Affiliation:

  • Cleveland Clinic

Location:

Activity

  • Sharecare News
    Sharecare News posted a story about Cardiology:

    MONDAY, Sept. 15, 2014 (HealthDay News) -- U.S. heart experts recommend doctors use a 14-point checklist rather than an electrocardiogram (ECG) when evaluating young people for underlying heart disease that could result in sudden cardiac arrest.

    The American Heart Association and the Amer...Full Article

  • Sharecare News
    Sharecare News posted a story about Internal Medicine:

    MONDAY, Sept. 15, 2014 (HealthDay News) -- Patients prescribed cholesterol-lowering drugs are more likely to fill their prescriptions and gain health benefits if the medications are cheaper generic brands, new research suggests.

    At issue are the cholesterol-lowe...Full Article

  • Sharecare News
    Sharecare News posted a story about Cardiology:

    MONDAY, Sept. 15, 2014 (HealthDay News) -- People who've had a heart attack are at greater risk of death if even one of nine critical steps in their treatment is missed, according to a new study.

    Researchers in the United Kingdom noted patients who missed a part of their treatment early ...Full Article

  • Sharecare News
    Sharecare News posted a story about Public Health:

    FRIDAY, Sept. 12, 2014 (HealthDay News) -- Older people exposed to high levels of black carbon -- the fine particle air pollution from traffic -- may have increased levels of leptin, a hormone linked to obesity, diabetes and heart disease, a new study suggests.

    Although the research doesn...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology/diabetes/metabolism:

    FRIDAY, Sept. 12, 2014 (HealthDay News) -- Combining insulin with a relatively new hormone-like drug appears to be a safer and more effective way to treat type 2 diabetes than current methods, a new review suggests.

    The drug belongs to a new class of injectable medications called "glucago...Full Article

  • Sharecare News
    Sharecare News posted a story about Emergency Medicine:

    THURSDAY, Sept. 11, 2014 (HealthDay News) -- An American medical missionary who survived infection with Ebola has donated blood to a colleague who's struggling to fight his own infection with the often deadly virus.

    Dr. Rick Sacra was given blood transfusions from Dr. Kent Brantly last Fr...Full Article

  • Sharecare News
    Sharecare News posted a story about Long-term Care:

    THURSDAY, Sept. 11, 2014 (HealthDay News) -- A new national analysis of U.S. nursing home prescription patterns says that more than half of people with advanced dementia are prescribed medications that are of questionable benefit.

    "The main concern centers on the under-appreciated burden ...Full Article

  • Sharecare News
    Sharecare News posted a story about Public Health:

    THURSDAY, Sept. 11, 2014 (HealthDay News) -- A new weight-loss medication for the overweight and obese has been approved by the U.S. Food and Drug Adminstration.

    Contrave is a combination of two already-approved drugs, naltrexone and bupropion, in extended-release form. The former is appr...Full Article

  • Michael Roizen, MD - Cleveland, OH - Internal Medicine
    Michael Roizen, MD posted a photo:
    For years there has not been a diagnostic tool to for Chronic Fatigue Syndrome. CFS affects 1 million North Americans. Check out article Dr. Oz and I wrote to learn what has changed http://bit.ly/1qHvSry.
  • Sharecare News
    Sharecare News posted a story about Caregiving:

    WEDNESDAY, Sept. 10, 2014 (HealthDay News) -- Your blood type may play a small role in your risk for dementia, a new study finds.

    People with blood type AB, which includes about 4 percent of the population, appear to have an increased risk for memory problems as they age. Over about three...Full Article

  • Sharecare News
    Sharecare News posted a story about Genetic Medicine:

    WEDNESDAY, Sept. 10, 2014 (HealthDay News) -- An expert panel has issued new guidelines for managing sickle cell disease, stressing the use of the drug hydroxyurea and transfusions for many with the genetic disorder.

    "This is a major step forward to try to put together all of the evidence...Full Article

  • Sharecare News
    Sharecare News posted a story about Pediatric Cardiology:

    TUESDAY, Sept. 9, 2014 (HealthDay News) -- Cholesterol-lowering statin drugs seem to help reduce the risk of cardiovascular disease in children who have a genetic cholesterol disorder, according to a long-term European study.

    Researchers looked at 194 children and teens in the Netherlands...Full Article

  • Sharecare News
    Sharecare News posted a story about Internal Medicine:

    TUESDAY, Sept. 9, 2014 (HealthDay News) -- Emergency room visits for high blood pressure jumped 25 percent in the United States in recent years, according to a new study.

    The finding -- based on nearly 4 million U.S. emergency room visits from 2006 to 2011 -- points to a need for people ...Full Article

  • Sharecare News
    Sharecare News posted a story about Urology:

    MONDAY, Sept. 8, 2014 (HealthDay News) -- Monitoring early stage prostate cancer instead of treating it may not be appropriate for all patients, especially black men, a new study indicates.

    According to background information with the study, there is currently controversy among oncologist...Full Article

  • Sharecare News
    Sharecare News posted a story about Urology:

    MONDAY, Sept. 8, 2014 (HealthDay News) -- Men newly diagnosed with prostate cancer often turn first to testosterone-depleting therapies, since male hormones help prostate tumors grow.

    But, those therapies almost always fail over time as the tumor develops resistance, according to oncologi...Full Article